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ABSTRACT 
Tartrazine (TZ) is an azobenzene artificial yellow dye for foods, drugs, and cosmetics. Quercetin is member of the flavonoid family. 
The current study investigated the protective effect of quercetin nanoparticles (QNPs) against TZ. Male albino rats were divided into 
group1:  control, group 2: TZ (50 mg/kg), group 3: QNPs (5 mg/kg), and group 4: QNPs+TZ. The results of the present study 
revealed that, the oral administration of TZ dye caused significantly increased liver biomarkers. Also, a marked effect on lipid 
profile and blood parameters was shown. In addition TZ induced an elevation in the examined oxidative stress biomarkers and 
decrease in glutathione peroxidases and acetylcholine esterase. TZ diminished exploration and rearing in open field test as well as 
elevation in GABA content and apoptosis as well as changes in tissues by histopathological examination. In fact, the results showed 
good influence of QNPs in improving injuries associated with TZ administration. 
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INTRODUCTION 
A wide sort of food additives, running into more than 
2,500 items used to preserve, dye or enhance foods 
1, 2, 3
 
are a consequence of industrialization and the 
development of food processing technology. They are 
approved for human utilization after studying its acute, 
sub-acute and chronic toxicities. The individual 
response varies not only according to dose, age, gender, 
nutritional status and genetic factors, but also according 
to long term disclosure to low doses 
4, 5, 6, 7
. 
Numerous metabolites of these substances, such as 
nitrous compounds, have been found to be carcinogens. 
Toxicity or benefit depends on to what degree food 
components affect absorption, excretion or the 
metabolism as a whole.  Because there may be 
interaction between different substances, the clarity of 
adequate safety limits for human consumption is 
further compounded 
8, 9
. 
Tartrazine (TZ) is  an  azobenzene  artificial  yellow  
dye whose  structure  features  a  tri-sodium  salt  of  3-
carboxy-5-hydroxy-1 (p-sulfophenyl) -4- 
(sulfophenylazo) pirazolone.  It is extensively used to 
dye sweets, chewing gum, jellies, puddings, juices, 
jams, mustard, sodas, drugs and cosmetics. It is reduced 
in the individual to an aromatic amine which is highly 
sensitizing. Its main metabolite identified to date is 
sulfanylic acid 
10, 11, 12, 13
. 
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Tartrazine is used as the food additive, most often 
responsible for allergic reactions. Although urticaria,  
asthma, purpura  and  eczema  have  been  described,  
essentially  affecting  individuals  allergy  to  aspirin, 
the underlying immunologic mechanism has proved 
elusive.  Some studies have suggested a humoral 
immune response brought about by the sulfanyl group 
14, 15, 16, 17
. Some countries such as Sweden, Switzerland 
and Norway  have  withdrawn TZ  on  the  basis  of  its  
anaphylactic  potential 
18
. Several  authors  have  
studied  the  carcinogenetic  and mutagenetic  
properties  of  TZ  
19, 20, 21, 22, 7
. 
Quercetin is members of   the flavonoid family 
23
. It   
has   anti-cancerogenic,  antiviral, anti-ischemic,  anti-
inflammatory  and   antiallergenic,  as  well as  
defensive  influence   in   atherosclerosis  and   
coronary  heart disease  
24
. Actually flavonoids  can   
prevent   oxidative  damage   as  a  result   of   their  
ability  to   scavenge  reactive   oxygen species 
25
 and   
metal  chelating  
26
. Noteworthy, quercetin present in 
the human diet as vegetables, herbs and edible fruits. 
Even with the medicinal benefits of quercetin, it has 
low bioavailability (less than 17% in rats and even 1% 
in human) 
27
 due to its reduced aqueous solubility, as a 
result, the clinical application of this drug greatly 
restricted. Hence, it becomes necessary to build up a 
system which could increase the solubility of quercetin. 
Nanoparticles are mainly suitable for drug delivery for 
water insoluble compounds such as quercetin 
27
. 
According to Noyes-Whitney equation  a decrease in 
particle size will lead to an increase in effective surface 
area which results in enhanced bioavailability 
28
.  
In fact, the body has defense   mechanisms against   
oxidative damage which are composed of   enzymatic 
and   non-enzymatic systems 
29
.   The   enzymatic 
mechanism is   made of   free   radical scavengers like 
catalase (CAT), superoxide dismutase (SOD) and   the   
glutathione-depend   enzymes such as 
glutathioneperoxidase (GPx),   and   glutathione-S-
transferase  
30, 31
. The   non-enzymatic  mechanism  
involves  certain  endogenous compounds  in   the   
body  as reduced glutathione (GSH) and   certain  
exogenous  compounds   taken   as  vitamins   E  and   
C,   and flavonoids 
29, 23
. 
The   aim   of   this   study   was   to   determine the   
effect   of   TZ exposure on male albino rats   and   to   
assess whether these effects can   be ameliorated   by 
quercetin nanoparticles (QNPs) two hours after TZ.  
MATERIAL AND METHODS 
Materials  
Food colors additives Tartrazine yellow (E102) was 
obtained from the local market and administered orally 
according to Walton et al. (1999) 
22
. Chitosan (CH), 
medium molecular weight and viscosity 190–310 kDa, 
acetic acid, tripolyphosphate (TPP) and Quercetin 
nanoparticles powder with an average particle diameter 
of about 45 nm were obtained from Sigma Chemical 
Co. (St. Louis, MO, USA). Alanine aminotransferase 
(ALT) and Aspartate aminotransferase (AST) kits were 
purchased from Spectrum-diagnostics Co. (Cairo, 
Egypt). Alkaline phosphatase (ALP), and acetylcholine 
esterase (AChE) kits were obtained from Diamond 
diagnostics. Glutathione peroxidase (GPx) kit was 
obtained from Randox diagnostics.  Reactive oxygen 
species (ROS), lipid peroxidation (LPO), and protein 
carbonyl (PC), were obtained from Sigma Chemical 
Company (preparation in lab) according to method in 
paper. 
All other chemicals used throughout the experiments 
were of the highest analytical grade available. 
Preparation of CH /QNPs 
A sequence of CH /QNPs beads were prepared based 
on were prepared by ionic cross-linking as the 
following method. Typically, 1.0 g of CH was 
dissolved using magnetic stirring in 50 mL of 0.1M 
acetic acid at 25°C for 20min until complete dissolved 
and viscose homogenous solution was obtained. 
Various amounts of QNPs; 0, 5%, 10% and 15% 
dispersed in 10 mL of distilled water were added 
slowly into the above CH solution. The obtained 
mixture was further stirred for 10min to obtain a 
homogenous system. Subsequently, the solution was 
extruded in the form of dewdrops, using a syringe (2 
mm diameter), into a solution (50 ml) containing TPP 
(3.0 g) and NaOH (2.0 g). The beads were remained in 
the mixture of solution overnight so as to crosslink with 
TPP. The pH of the suspension was adjusted to 5 by 
adding 0.1 M NaOH and the stirring was continued for 
another 30 min. without pH adjustment. 
Experimental Animals    
Adult male albino rats (40 animals) weighing between 
195 ± 10g were used in the present study. The rats were 
obtained from the animal house of the National 
Organization for Drug Control and Research Egypt 
(NODCAR). The animals were kept under standard 
laboratory conditions of light/dark cycle (12/12 h), 
temperature (20 -25
◦
C), and allowed free access to food 
(standard pellet diet), water ad libitum for one week. 
Animals were treated gently; squeezing, pressure and 
tough maneuver were avoided. The investigation was 
complied with the Guide for Care and Use of 
Laboratory Animals of the National Institutes of Health 
(NIH publication No. 85–23, revised 1996).  
Experimental design 
Rats were randomly divided into four groups (n=10). 
Groups were treated as follows: 
Control group rats were administrated with one ml 
saline solution.TZ group was given TZ (50 mg/kg, 
orally). QNPs group was given (5 mg/kg, orally). Rats 
of the protective groups were given (50mg TZ + 5mg 
QNPs, orally). The administered QNPs and TZ were 
given for 30 days. 
1. Behavioral test; open field test: 
Open field test was carried out at the end of the 
treatment period according to Sethi et al, (2008) 
32
, 
where the latency time, ambulation frequency, 
grooming frequency, and rearing frequency were 
measured.  
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2. Sample preparation 
At the end of the experimental period, all rats were 
fasted for 12 hours and then the blood samples were 
collected from venous sinus in centrifuge tubes to 
separate serum by centrifugation at 3000 rpm for 15 
minutes. Sera were kept at -80
o
C for biochemical 
analyses. In addition, the liver and the cerebellum were 
dissected and isolated immediately, plotted free from 
adhering blood, and dried between two filter papers. 
Each tissue sample was then weighed. Parts from liver 
and cerebellum were kept in 10% formalin to examine 
histologically and the other parts were kept at -80
o
C for 
biochemical examination in liver and cerebellum 
tissues. 
3. Biochemical analysis 
3.1- Measurement of blood parameters 
Hemoglobin (Hb %) concentration, red blood cell 
(RBC) count and hematocrit (HCT%) were estimation 
using a semiautomatic hematological analyzer 
(SWELAB IEO Model). The auto counter utilized 20 μl 
of blood in 16 ml of a commercially prepared diluent. 
The machine’s ability to count cells was based on the 
principle of electronic impedance. In addition, serum 
glucose level was as described by Trinder, (1969) 
method 
33
. 
3.2- Measurement of liver functions 
Determination of aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT) activities were 
performed according to the method of Reitman and 
Frankel, (1957) 
34
. Determination of alkaline 
phosphatase (ALP) was determined in serum according 
to the method of was determined   by Belfield   and   
Goldberg, (1971) 
35
. 
3.3- Measurement of Lipid   profile   
Serum LDL-cholesterol concentration was estimated   
by the   method   of  Wieland   and Seidel, (1983) 
36
, 
for enzymatic   colorimetric   method. Serum  HDL  
concentration  was  estimated   by  the   method   of  
Burstein   et  al, ( 1970 ) 
37
,   for  enzymatic   
colorimetric   method. Besides, serum cholesterol and 
triglyceride concentration were estimated by the   
method   described   by Zollner   and   Kirsch, (1962) 
38
 that is an enzymatic colorimetric method. 
3.4- Measurement of reactive oxygen species (ROS) 
content. 
A modified version of a previously described assay for 
the intracellular conversion of nitro blue tetrazolium 
(NBT) to form azan by superoxide anion was used to 
measure the generation of reactive oxygen species 
39
. 
3.5- Measurement of malondialdehyde content 
 Lipid peroxides formation was determined in liver and 
cerebellum homogenates as thiobarbituric acid reactive 
substances (TBARS). It was determined according to 
the method of (Uchiyama and Mihara, 1978) 
40
. 
 
 
3.6- Measurement of glutathione peroxidase (GPx) 
activity: 
Glutathione peroxidase activity determined in liver and 
cerebellum homogenates according to the method of 
(Brigelius-Flohe, 1999) 
41
. 
3.7- Measurement of Protein Carbonyl 
Concentration: 
Protein carbonyl concentration was measured in liver 
and cerebellum by first forming labeled protein 
hydrazone derivatives using 2, 4-dinitrophenyl 
hydrazide 
42
. 
3.8- Measurement of Myelopreoxidase (MPO) 
Activity 
Myeloperoxidase activity was evaluated in liver and 
brain tissues according to Bradley et al, (1982) 
43
.  
3.9- Measurement of acetyl cholinesterase (ACHE) 
activity  
The Procedure used for the determination of 
Cholinesterase activity in the cerebellum of rats is a 
modification of the method of Ellman et al, (1961) 
44
 
as described by Gorun et al, (1978) 
45
. The principle of 
the method is the measurement of the rate of production 
of thiocholine as a result of acetylthiochline hydrolysis. 
3.10- Determination of GABA, 5-HT, NE and DA 
contents  
Cerebellum gamma-aminobutyric acid (GABA), 
serotonin (5-HT), norepinephrin (NE) and dopamine 
(DA) were estimated according to method of Ciarlone 
(1978) 
46
. The method is based on fluorometric test in 
which fluorescent product results from reaction with 
orthophthalaldehyde solution in case of 5-HT and 
reaction with alkaline sulfite and iodine solution in case 
of NE and DA.    
3.11- Brain (cerebellum) and liver Caspase 3 
Immunohistochemical Examinations 
Paraffinized brain (cerebellum) and liver sections were 
deparaffinized and rehydrated through xylene and 
alcohol for immunohistochemical assessment of 
Caspase 3. Antigen unmasking was performed by 
incubating the sections for 20 min in citrate buffer 
(Thermo Fisher Scientific, Fremont, CA; pH 6.0) at the 
boiling point then cooled. Sections were then incubated 
overnight at 4 °C either with the rabbit polyclonal anti-
Caspase 3 (1:200; Thermo Fisher Scientific) primary 
antibody. After washing with PBS, the slides were 
incubated for 30 min at 37 °C with the biotinylated 
secondary antibody then with the Vector Elite ABC kit 
(Elite reagent Avidin DH and biotinylated horseradish 
peroxidase H reagents; Vector Laboratories Inc., 
Burlingame, C A). After another wash with PBS, the 
antibody–biotin–avidin–peroxidase complex was 
developed using diaminobenzidinetetrahydrochloride 
(DAB Substrate K it, Vector Laboratories I nc.). 
Sections were counterstained with hematoxylin, 
dehydrated, and cleared in xylene then cover slipped, 
where the reaction appeared as a brown cytoplasmic 
reaction (400×). 
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Methodology of image morphometry for inspection 
of the slides 
Images of histological sections were analyzed by Image 
J software to measure the optical density of the 
apoptotic area 
47
.  
3.12- Histopathological examination of 
cerebellum and liver tissues 
For   histopathological examination, a liver and 
cerebellum tissue was dissected and   tissue samples 
were fixed in   10%   neutral formalin for 24 h.  Then 
samples were processed   using   a graded ethanol series   
and embedded in   paraffin.  Paraffin   sections were cut 
into 6µm-thick slices   and   stained with hematoxylin 
and   eosin for   light microscopic examination. 
Statistical analysis 
Results were expressed as mean ± SEM. Statistical 
analysis was carried out using one-way analysis of 
variance (ANOVA) followed by Tukey–Kramer 
Multiple Comparison Test. Probability values of less 
than 0.05 were considered statistically signiﬁcant. 
Whereas the graphs were drawn using a prism 
computer program (GraphPad software Inc. V5, San 
Diego, CA). 
RESULTS 
Characterization of QNPs: 
Figure (A&B), showed morphology and size of QNPs 
using SEM photographs. QNPs exhibited particles 
uniformity in size, less crystallinity, and absence of 
larger particles (Figure A). As depicted in the image, 
the particles possessed uniform shape. The size of all 
particles was found to be less than 200 nm (Figure B).
 
 
Figure (A&B): Photomicrographs & investigation of morphology and size of QNPs using SEM photographs. 
 
Effect of QNPs on TZ induced behavioral alteration; 
open field test: 
Figure (1), illustrated the parameters related to the open 
field test. Noteworthy,  the latency time (Figure 1A) 
increased significantly to 3 folds in TZ group as 
compared to control group, whereas QNPs alone and as 
treatment (QNPs+TZ group) induced significant 
decreases in the time (63% and 59%, respectively) as 
compared to TZ group. On the other hand the 
ambulation frequency (Figure 1B) decreased 
significantly by 45% in TZ group as compared to control 
group. While the ambulation frequencies were 
augmented in QNPs and QNPs +TZ groups (nearly to 2 
folds) as compared to TZ group. In addition, TZ 
decreased the grooming frequency (Figure 1C) by 62% 
as compared to control group, whilst the grooming 
frequencies were incremented in QNPs and QNPs +TZ 
groups (nearly to 2 folds) as compared to TZ group. 
Also the rearing frequency (Figure 1D) was decreased 
significantly by 26% as compared to control group, but 
it was increased significantly in QNPs +TZ group by 
27% as compared to TZ group. 
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Figure 1: Effects of QNPs (5mg) on latency [A] , ambulation frequency [B], grooming frequency [C], and rearing 
frequency [D] of open field behavioral test  in TZ  (50 mg/kg) induced brain injury in rats. 
 
Data represents mean (n = 8-10) ±SEM, 
* #
 P<0.05 
relative to Control & TZ groups, respectively. Statistical 
analysis was carried out by one way ANOVA followed 
by Tukey- Kramer Multiple Comparison Test. 
Evaluation of Body weight, blood parameters (Hb%, 
RBCs, and HCT %) and serum glucose level 
The obtained data in table (1) revealed that, 
administration of QNPs alone reduced the body weight 
significantly compared to TZ group by 16%. Also the 
obtained results showed that, administration of QNPs + 
TZ decreased the body weight significantly compared to 
TZ group by 14%. 
Table (1) investigated that TZ significantly reduced 
Hb%, RBCs, and HCT% by 24%, 24% and 26%, 
respectively, compared to control group. Besides TZ 
induced increment in serum glucose level by 41% as 
compared to control group. In contrary, administration 
of QNPs alone almost didn't change Hb%, RBCs, and 
HCT% as compared to control group, but as compared 
to TZ group QNPs increased these parameters by 33%, 
33% and 32% , respectively. As well QNPs reduced the 
serum glucose level compared to TZ group by 65%. 
Noteworthy, administration of QNPs + TZ revealed 
significant increased in Hb%, and RBCs as compared to 
TZ group by 28% and 26%, respectively. Moreover 
administration of QNPs + TZ reduced the serum glucose 
level compared to TZ group by 15%. 
  
Table (1) Ameliorative effects of quercetin nanoparticles against tartrazine toxicity on the body weight and 
blood parameters (Hb%, RBCs, and HCT %) and serum glucose level: 
 
Parameters 
Body weight (g) Hematology Glucose 
 (mg/dl) Initial Final Hb% RBCs (106/mm3) HCT (%) 
Control 195.5 ±1.50 262.0± 2.17 14.81 ±0.35 5.10 ±0.32 46.00 ±0.53 96.00 ±0.38 
TZ   
(50 mg/kg) 
196.5 ±2.18 310.5 ±2.83* 
11.20 ±0.41* 3.90±0.20* 34.00±0.41* 135.00± 0.69* 
QNPs 
 (5mg/kg) 
194.5 ± 2.15 261.0 ± 2.42# 
14.84± 0.18# 5.20 ± 0.24# 45.00 ±0.52# 94.00 ± 0.47# 
 QNPs + TZ 197.0 ± 2.45 266.0 ± 1.83
# 14.37 ±0.27# 4.90 ± 0.19# 35.00 ±0.63 115.00 ±0.58# 
Values are expressed as mean ± S.E. *#p <0.05 relative to control & TZ groups, respectively. TZ= tartrazine, QNPs = quercetin 
nanoparticles.  
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Effect of QNPs on TZ induced toxicity on AST, ALT 
and ALP levels: 
Table (2) illustrated that administration of QNPs alone 
reduced levels of AST, ALT and ALP as compared to 
TZ group by 42%, 53% and 67%, respectively. As well 
administration of QNPs + TZ revealed significant 
decreased in  AST, ALT and ALP levels as compared to 
TZ group by 38%, 50% and 63%, respectively. 
 
Table (2) Ameliorative effects of quercetin nanoparticles against tartrazine toxicity on AST, ALT and ALP 
levels in rats. 
Parameters AST (U/mL) ALT (U/mL) ALP (U/mL) 
Control 38.57 ± 2.83 58.17 ± 4.21 50.08 ± 5.23 
TZ  (50 mg/kg) 63.42 ± 2.61* 121.0 ± 4.18* 148.63 ± 5.31* 
QNPs (5mg/kg) 36.92 ± 2.44 
#
 56.41 ± 3.96 
#
 49.73 ± 5.18 
#
 
QNPs + TZ 39.14 ± 2.38 
#
 60.39 ± 4.17 
#
 54.81 ± 4.92 
#
 
Values are expressed as mean ± S.E. *#p <0.05 relative to control & TZ groups, respectively. TZ= tartrazine, QNPs = quercetin 
nanoparticles. 
 
Effect of quercetin nanoparticles against Tartrazine-
induced lipid profile markers 
Data in table (3) showed that administration of QNPs 
alone reduced levels of serum total cholesterol, 
triglyceride and LDL-C as compared to TZ group by 
35%, 55% and 38%, respectively. On other hand, QNPs 
administration, as compared to TZ administration, raised 
HDL-C level by 67%. Besides, administration of QNPs 
+ TZ revealed significant decreased in levels of serum 
total cholesterol, triglyceride and LDL-C as compared to 
TZ group by 34%, 49% and 27%, respectively. In 
addition, administration of QNPs + TZ increased HDL-
C level by 35% as compared to TZ alone. 
  
Table 3: Ameliorative effects of quercetin nanoparticles against tartrazine affected lipid profile in serum rat. 
 
Parameters 
Cholesterol 
(mg/dL)   
Triglyceride 
(mg/dL)   
HDL-Cholesterol  
(mg/dL) 
LDL-  Cholesterol  
(mg/dL)   
Control 83.80 ± 2.76 68.9 ± 2.84 32.56 ± 0.80 41.24 ± 0.82 
TZ (50 mg/kg) 128.36 ± 2.44* 141.0 ± 1.84* 21.41 ± 0.51* 61.18 ± 0.59* 
QNPs (5mg/kg) 83.44 ± 2.31
#
 63.9 ± 1.84
#
 35.81 ± 0.62
#
 38.22 ± 0.61
#
 
 QNPs + TZ 85.27 ± 2.23
#
 71.4 ± 1.84
#
 28.91 ± 0.43
#
 44.71 ± 0.68
#
 
Values are expressed as mean ± S.E. *#p <0.05 relative to control & TZ groups, respectively. TZ= tartrazine, QNPs = quercetin 
nanoparticles.  
 
Evaluation of ROS, MDA, GPx, PC, and MPO in 
liver tissue   
Table (4) investigated that TZ significantly augmented 
ROS, MDA, PC and MPO by 24%, 4 folds, 26%, and 
39%, respectively, compared to control group. Besides 
TZ reduced GPx by 40% as compared to control group. 
In contrary, administration of QNPs alone almost didn't 
change ROS, MDA, PC, and GPx as compared to 
control group, but as compared to TZ group  QNPs 
decreased ROS, MDA, PC and MPO by 17%, 77%, 
16%, and  60%, respectively. As well QNPs increased 
activity of GPx compared to TZ group by 68%. 
Noteworthy, administration of QNPs + TZ revealed 
significant declined in ROS, MDA, PC and MPO by 
18%, 75%, 23%, and  52%, respectively, as compared to 
TZ group. Furthermore administration of QNPs + TZ 
increased activity of GPx compared to TZ group by 
69%.
 
Table 4: Ameliorative effects of quercetin nanoparticles against tartrazine affected reactive oxygen species 
(ROS), malondialdehyde (MDA), and protein carbonyl (PC) contents as well as GPx and MPO activities in rat 
liver 
Parameters 
ROS 
(µmol /g tissue) 
MDA  
(nmol/g tissue) 
GPx 
(IU/g tissue) 
PC  
(nmol /mg) 
MPO 
(U/g tissue) 
Control 17.10 ± 0.21 9.84 ± 0.08 23.52 ± 0.61 25.0 ± 0.61 67.3 ± 0.614 
TZ  
 (50 mg/kg) 
21.28 ± 0.44* 41.00 ± 0.09* 14.21 ± 0.31* 31.4 ± 0.55* 93.2 ± 1.4* 
QNPs 
 (5mg/kg) 
17.65 ± 0.21
#
 9.43 ± 0.09
#
 23.90 ± 0.61
#
 24.30 ± 0.51
#
 37.4 ± 1.82*
#
 
 QNPs + TZ 17.32 ± 0.82
#
 10.25 ± 0.10
#
 24.05 ± 0.21
#
 26.3 ± 0.71
#
 45.0 ± 4.11*
#
 
Values are expressed as mean ± S.E. *#p <0.05 relative to control & TZ groups, respectively. TZ= tartrazine, QNPs = quercetin 
nanoparticles. 
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Evaluation of ROS, MDA, GPx, PC, MPO, and AchE 
in cerebellum tissue   
Table (5) disclosed that TZ significantly augmented 
ROS, MDA, PC and MPO by 57%, 5 folds, 33%, and 
79%, respectively, compared to control group. 
Additionally TZ reduced GPx and AChE by 47%, and 
18%, respectively, as compared to control group. In 
contrary, administration of QNPs alone almost didn't 
change ROS, MDA, GPx, PC, MPO, and AChE as 
compared to control group, but as compared to TZ 
group  QNPs decreased ROS, MDA, PC and MPO by 
37%, 80%, 25%, and  28%, respectively. As well QNPs 
increased activities of GPx and AChE compared to TZ 
group by 85%, and 5%, respectively. Moreover, 
administration of QNPs + TZ exposed significant 
declined in ROS, MDA, PC and MPO by 36%, 77%, 
21%, and 29%, respectively, as compared to TZ group. 
Furthermore, administration of QNPs + TZ increased 
activities of GPx and AChE compared to TZ group by 
76% and 20%, respectively. 
  
Table 5: Ameliorative effects of quercetin nanoparticles against tartrazine affected reactive oxygen species 
(ROS), malondialdehyde (MDA), and protein carbonyl (PC) contents as well as GPx, MPO, and acetylcholine 
esterase (AChE) activities in rat cerebellum. 
Parameters 
ROS (µmol 
/ g tissue) 
MDA  
(nmol/g tissue 
GPx 
(IU/g tissue) 
PC 
(nmol /mg) 
MPO  
(U/ g tissue) 
AChE 
(U/g tissue) 
Control 5.22± 0.17 8.61 ± 0.21 16.42 ± 0.51 19.09 ± 0.43 42.1 ± 2.94 628.43 ± 2.45 
TZ  (50 mg/kg) 8.21 ± 0.43* 40.2 ± 0.16* 8.63 ± 0.44* 25.32 ± 0.15* 75.4 ±3.25* 513.20 ± 4.21* 
QNPs (5mg/kg) 5.19 ± 0.52
#
 8.2 ±0.13
#
 16.00 ±0.68
#
 19.00 ± 0.32
#
 54.7 ±4.09
#
 538.19 ± 4.62
#
 
 QNPs + TZ 5.28 ±0.36
#
 9.43 ± 0.19
#
 16.38 ±0.39
#
 20.03 ± 0.62
#
 53.6 ±3.63
#
 613.28 ± 3.19
#
 
Values are expressed as mean ± S.E. *#p <0.05 relative to control & TZ groups, respectively. TZ= tartrazine, QNPs = quercetin 
nanoparticles.  
Effect on GABA, 5-HT, NE and DA contents 
Figure (2) showed that GABA content (Figure 2A) was 
increased significantly nearly to 2 folds as compared 
with control group, at the same time GABA contents 
were declined in QNPs and QNPs+TZ groups by 30% 
and 15%, respectively, as compared to TZ group. On the 
other hand, 5-HT contents (Figure 2B) were decreased 
significantly by 16% in TZ, and QNPs+TZ groups as 
well as 21% in QNPs as compared to control group. 
Conversely, NE (Figure 2C) and DA (Figure 2D) 
contents were increased significantly by 44% and 32%, 
respectively, as compared with TZ group. 
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Figure 2: Effects of QNPs (5mg) on cerebellum ɤ-Amino butyric acid (GABA) [A] , Serotonin (5-HT) [B], Nor-epinephrine 
(NE) [C], and Dopamine (DA) [D] of open field behavioral test  in TZ  (50 mg/kg) induced brain injury in rats. 
Data represents mean (n = 8-10) ±SEM, * # P<0.05 relative to Control & TZ groups, respectively. Statistical analysis was carried out 
by one way ANOVA followed by Tukey- Kramer Multiple Comparison Test. 
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Immunohistopathological examination of liver and 
cerebellum tissues 
By using caspase 3 antidote stain for cerebellum, figure 
(3A) illustrated that TZ induced apoptosis by significant 
increasing in expression caspase 3 as compared to 
control group. Noteworthy, figure (3) revealed that 
QNPs or QNPs+TZ improved the apoptosis significantly 
as compared to TZ group. 
Likewise, figure (3B) illustrated that each of QNPs or 
QNPs+TZ improved the apoptosis significantly in liver 
tissues as compared to TZ group. 
 
 
Figure 3: Effects of QNPs (5mg) on optical density of caspase 3 expresssion in cerebellum (A) and liver (B) 
tissues in TZ (50 mg/kg) induced brain-liver injuries in rats. 
 
Data represents mean (n = 15-20) ±SEM, 
* #
 P<0.05 
relative to Control & TZ groups, respectively. Statistical 
analysis was carried out by one way ANOVA followed 
by Tukey- Kramer Multiple Comparison Test. 
Histopatholgical examination of liver and cerebellum 
tissues 
By using H&E stain, figure (4A) illustrated that TZ 
induced necrosis and pyknosis of purkinje cells in 
cerebellum tissues. On the other hand QNPs or 
QNPs+TZ made marked improvement in cerebellum 
tissues as compared to TZ group.  
Similarly, figure (4B) showed that liver tissues after 
administration of TZ, there are induction of Kupffer 
cells activation, congestion of central vein and sinusoids, 
and focal hepatic necrosis associated with inflammatory 
cells infiltration. Alternatively, QNPs or QNPs+TZ 
made marked improvement in cerebellum tissues as 
compared to TZ group. 
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Figure 4: Effects of QNPs (5mg) on histopathological changes in cerebellum (A) and liver (B) tissues in TZ (50 
mg/kg) induced brain-liver injuries in rats. Photomicrographs of rat cerebellum and liver sections stained with 
H&E (X400).   
DISCUSSION 
Food additives, considered as xenobiotic, have a 
significant effect in currently abundant and nourishing 
food sources, and allow people to be pleased. Really, 
they may have several metabolites, such as monosodium 
glutamate and nitrous compounds that are found to be 
carcinogens 
48
.  
Noteworthy, the current study revealed that 
administration of chosen dose of TZ caused marked 
raise in latency time, as well decrease in ambulation 
frequency, grooming frequency, and rearing frequency 
of open field behavioral test. These indicated anxiety- 
and depression-like behaviors in rats and these data were 
in conflict with the previous study 
49
. We suggested that 
altered apoptotic gene expressions or damage related to 
cerebellum were involved. On the other hand, treatment 
with QNPs improved these TZ deleterious effects as it 
has anti-apoptotic effect 
50
.  
In this, TZ caused a significant increase in the body 
weight compared to normal control group. Indeed, an 
increase in the body  weight  over  20% above the mean 
body weight is considered as obesity 
51
. Similar results 
have also been reported 
52, 53
. Meanwhile, using of QNPs 
as treatment improved the body weight.  
Additionally, TZ declined Hb%, RBCs count and HCT% 
significantly as in previous studies 
54, 55
. These changes 
may be due to the prevention of red blood cell synthesis 
via inhibition of erythropoisis in the bone marrow 
56
 as 
well as increase fragility and progressive destruction of 
RBCs due to binding of free radicals produced by TZ 
57
.  Conversely, QNPs administration recovered blood 
markers and might be due to antioxidant activity of 
QNPs 
58
. 
In fact, TZ treatment affected liver function tests. These 
results may be attributed  to hepatocellular damage 
caused   by the   toxic   effect of TZ which was indicated   
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by histopathological examination. Alternatively, there 
were current recovers in AST and ALT levels and ALP 
activity in QNPs + TZ group which may be due to 
improvement in liver tissue as appear by 
histopathological examination.  
Herein, TZ induced harm regarding to lipid profile as 
another study 
59
. On the other hand, QNPs improved the 
lipid profile. Igarashi and Ohmuma,  (1995 ) 
60
 stated  
that, quercetin  decreased  serum total cholesterol level  
in  rats  through  increasing  its  fecal excretion.  In 
addition, quercetin  reduces de  novo  synthesis  of  fatty  
acids  and  consequently  cholesterol  biosynthesis  and  
lipoproteins  formation  
61
. 
Herein, ROS, MDA and PC levels and MPO activity 
increased significantly in liver and brain tissues 
accompanied with a significant decrease in the activity 
of GPx after administration of TZ, as other studies 
62, 63
. 
In addition, the measurement of PC has some advantages 
as the relative early formation and the relative stability 
of carbonylated proteins 
64
. In contrast QNPs showed 
valuable effects on liver and brain oxidation by 
enhancing antioxidant enzyme activity and decreasing 
pro-oxidant effect 
25
.  
Regarding to AChE activity, TZ administration caused 
significant inhibition in its activity in the brain tissue. 
While, QNPs showed improvement in AChE activity. 
Moreover, TZ administration led to decrease in 5-HT 
level in cerebellum which may be due to free radicals 
that generated when azo dyes metabolized by intestinal 
bacteria. These free radicals inhibited formation of 
adenosine triphosphate ATP that cause reduces synthesis 
or re-uptake of neurotransmitter in the presynaptic cell 
65
. Additionally, elevated GABA level by TZ may be 
due to inhibition of the voltage-dependent calcium 
channels, whereas treatment with QNPs improved the 
GABA level in cerebellum. 
CONCLUSION 
These protective effects of QNPs against TZ induced 
hepato- and neuro-toxicities may be due to antioxidant, 
anti-inflammatory and anti-apoptotic effects.    
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